Private Equity 8 Hours

Last updated: June 17, 2026, 8:30 PM ET

Board Moves & Market Signals

Roelof Botha joined SpaceX’s board days after the rocket‑maker completed the largest IPO in history, underscoring private‑equity talent migrating to high‑growth tech assets. The appointment follows a wave of venture veterans taking board seats at post‑IPO firms, a trend that could tighten governance standards as investors seek to protect inflated valuations. Meanwhile, veteran investor Chi‑Hua Chien warned that AI winners will avoid selling AI, a view that may shape how PE firms evaluate future software exits, emphasizing product ownership over short‑term monetisation.

Strategic Acquisitions in Healthcare and Tech

Altaris agreed to a $375m take‑private of Simulations Plus, pricing shares at $18.50 each and expanding its foothold in health‑technology modelling tools. In parallel, Singlepoint Healthcare closed its purchase of infusion services provider Healix, adding a specialty‑care platform that complements its existing inflammatory‑disease portfolio and positions the DFW‑backed group for cross‑sell opportunities. These deals illustrate a broader PE focus on consolidating fragmented health‑service niches to capture steady cash flows amid rising demand for outpatient treatments.

Infrastructure and Software Playbooks

KPS Capital injected capital into Jennmar, with existing shareholder Falcon Point retaining a sizeable minority stake, signalling confidence in the infrastructure‑products market despite supply‑chain headwinds. At the same time, a Blackstone‑led consortium secured control of Medallia as Thoma Bravo wrote down a $5bn loss on the software asset, highlighting the volatility of customer‑experience platforms and the willingness of large‑cap buyout funds to step in when legacy owners unwind. The coordinated moves across infrastructure and Saa S suggest PE firms are balancing long‑term asset stability with opportunistic acquisitions of distressed tech holdings.